DAIC

FEBRUARY 22, 2024

He previously served on the HVS Board of Directors and has led the HVS AVIATOR Registry, an international registry examining outcomes after aortic valve surgery. I am very excited and honored to lead the Heart Valve Society and further consolidate its role as a unique society dedicated to valvular heart disease.

Heart Valves 142

Heart Valves Aortic valve Aortic Sudden Cardiac Death 142

Med Page Today

MARCH 30, 2025

(MedPage Today) -- CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within 72 hours after TAVI or.

Aortic valve 52

Aortic valve Embolism Strokes Stroke 52

Becker's Hospital Review - Cardiology

JANUARY 5, 2024

A recent study found patients who undergo transcatheter aortic valve replacement have higher risk of stroke for up to two years after the procedure.

Aortic valve 69

Aortic valve TAVR Strokes Stroke 69

MIBHS

DECEMBER 30, 2022

A normal functioning aortic valve has three leaflets, usually referred to as cusps, and is positioned at the end of the left ventricle. This valve is the main pump that delivers oxygenated blood to the entire body. Today we take a deep dive into aortic valve replacement, so you can have the knowledge you need.

Aortic valve 52

Aortic valve Aortic Stenosis Hospital 52

Heart BMJ

MAY 10, 2024

Objectives The use of cerebral embolic protection (CEP) during transcatheter aortic valve implantation (TAVI) has been studied in several randomised trials. We aimed to perform a systematic review and Bayesian meta-analysis of randomised CEP trials, focusing on a clinically relevant reduction in disabling stroke.

Aortic valve 52

Aortic valve Embolism Aortic Strokes 52

Open Heart

JANUARY 19, 2025

Aim This study aimed to systematically review and analyse the existing evidence on outcomes of emergency transcatheter aortic valve implantation (eTAVI) and emergency balloon aortic valvuloplasty (eBAV) in CS patients. Despite advancements in emergency interventions, the optimal treatment approach remains uncertain.

Cardiogenic Shock 52

Cardiogenic Shock Aortic Stenosis Aortic valve 52

The New England Journal of Medicine

JANUARY 15, 2025

Among patients with asymptomatic severe aortic stenosis, early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes.

Stenosis 74

Stenosis Aortic Aortic valve TAVR 74

Medical Xpress - Cardiology

SEPTEMBER 13, 2024

A review in The Lancet finds that 20% of the world population carries a genetic risk factor for cardiovascular diseases such as heart attacks, strokes, and aortic valve stenosis: Increased levels of a lipid particle called lipoprotein(a). It is the most common genetic cause of cardiovascular diseases.

Aortic valve 90

Aortic valve Heart Disease Heart Attack Heart attacks 90

All About Cardiovascular System and Disorders

APRIL 1, 2024

Transcript of the video: Closure line of aortic valve on M-Mode echocardiogram, is seen as central line, while in bicuspid aortic valve, it is an eccentric closure, nearer to one of the walls of the aorta. That is an important feature of bicuspid aortic valve on M-Mode echocardiogram. This is a closure line.

Aortic valve 52

Aortic valve Bicuspid/Mitral Aortic Echocardiogram 52

Frontiers in Cardiovascular Medicine

FEBRUARY 22, 2024

Aims Perioperative stroke remains a devastating complication after transcatheter aortic valve implantation (TAVI), and using a cerebral embolic protection device (CEPD) during TAVI may reduce the occurrence of stroke according to some studies. The risk of stroke was lower in the CEPD group: RR 0.68, 95% CI 0.49–0.96,

Aortic valve 64

Aortic valve Embolism Aortic Strokes 64

Circulation

NOVEMBER 11, 2024

Seven studies showed that TAVR patients had a similar 1-year stroke risk to SAVR patients (OR 0.92, 95% CI 0.64 Circulation, Volume 150, Issue Suppl_1 , Page A4142104-A4142104, November 12, 2024. All statistical analyses were conducted using Review Manager (Rev Man, Version 5.4; The Cochrane Collaboration, Copenhagen, Denmark).Results:After

Aortic valve 40

Aortic valve Aortic TAVR Strokes 40

DAIC

MARCH 4, 2025

22, 2025More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the American Heart Association 2025 Heart Disease and Stroke Statistical Update. AS occurs when the aortic valve narrows, restricting blood flow from the heart to the body. tim.hodson Tue, 03/04/2025 - 14:11 Feb.

Heart Valves 52

Heart Valves Aortic valve Aortic Stenosis 52

DAIC

MARCH 25, 2024

Fethi Benraouane , and Dr. Molham Aldeiri , have successfully performed the first series of transcarotid Transcatheter Aortic Valve Replacement (TAVR) procedures ever done in Southeast Houston. This novel approach potentially decreases the risk of stroke and vascular complications and makes more options available for patients.

TAVR 111

TAVR Open-Heart Surgery Aortic valve Aortic 111

American College of Cardiology

OCTOBER 29, 2024

The goal of the PROTECTED TAVR trial was to evaluate the efficacy of intraprocedural cerebral embolic protection (CEP) in reducing strokes among patients undergoing transfemoral TAVR for aortic stenosis.

Aortic valve 45

Aortic valve Aortic TAVR Strokes 45

Frontiers in Cardiovascular Medicine

OCTOBER 24, 2024

There were no statistically significant differences in terms of stroke, paravalvular leak, mechanical ventilation time, blood transfusion requirements, pacemaker implantation, reexploration for bleeding, conversion, wound infection, or in-hospital stay. This was a retrospective, single-center observational study.

Aortic valve 52

Aortic valve Aortic Atrial Fibrillation Pacemaker 52

DAIC

MARCH 31, 2025

Data shows, versus surgery, the Evolut transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years, strong valve performance and durable clinical outcomes. Evolut TAVR vs. 9.3%

TAVR 52

TAVR Stenosis Aortic Outcomes 52

DAIC

APRIL 30, 2024

SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. The majority require explant of the TAVR device and SAVR, which significantly increases the risk of operative mortality and stroke. More than 5,500 multi-valve procedures were performed in the U.S.

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

DAIC

APRIL 11, 2024

TAVR and SAVR are procedures to replace a damaged aortic valve that is not functioning properly. guidelines recommend TAVR, a catheter-based approach in which the new valve is threaded to the heart through a blood vessel in the groin or chest, over open-heart SAVR for older patients and those with high cardiovascular risk.

TAVR 111

TAVR Aortic valve Aortic COVID-19 111

Journal of the American Heart Association

FEBRUARY 13, 2024

BackgroundAcute ischemic stroke complicates 2% to 3% of transcatheter aortic valve replacements (TAVRs). Fifty‐seven patients (1.7%) experienced a periprocedural stroke. The incidence of acute stroke was significantly higher among patients with a bovine arch compared with those with a nonbovine arch (3.6%

Aortic valve 40

Aortic valve Anatomy Aortic TAVR 40

Journal of the American Heart Association

MARCH 13, 2025

BackgroundLp(a) (lipoprotein(a)) is an independent risk factor for calcific aortic valve stenosis (CAVS). Journal of the American Heart Association, Ahead of Print. Whether patients with CAVS and high Lp(a) levels are at higher risk of valvular or cardiovascular events is unknown.

Aortic valve 45

Aortic valve Coronary Artery Bypass Graft Stenosis Aortic 45

DAIC

MAY 1, 2024

According to the Centers for Disease Control and Prevention (CDC), heart disease and stroke rank as the first and fifth leading causes of death in the nation. About 276,000 patients have undergone a TAVR procedure in the United States. About 276,000 patients have undergone a TAVR procedure in the United States.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105

Open Heart

MAY 12, 2023

Objective To evaluate whether transcatheter or surgical aortic valve replacement (TAVR or SAVR) affects clinical and haemodynamic outcomes in symptomatic patients with moderately-severe aortic stenosis (AS). <aortic valve area (AVA)<1.5 <aortic valve area (AVA)<1.5 cm 2 , 3.0<peak

Aortic valve 52

Aortic valve Aortic Stenosis TAVR 52

Journal of the American Heart Association

MARCH 21, 2025

BackgroundWe aimed to reevaluate randomized controlled trial data on outcomes of cerebral embolic protection device use during transcatheter aortic valve implantation. Primary outcomes included all stroke, disabling stroke, and allcause mortality.

Aortic valve 40

Aortic valve Embolism Aortic Strokes 40

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). Poverall=0.099) and all stroke (30 days: 1.0% Poverall=0.522; 1 year: 10% versus 2.3%

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

Circulation: Cardiovascular Interventions

MARCH 26, 2025

BACKGROUND:Current guidelines recommend surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and unfavorable iliofemoral access. Circulation: Cardiovascular Interventions, Ahead of Print. At 1-year follow-up, there were no significant differences between groups in the primary outcome rates (SAVR, 19.7%

Aortic valve 40

Aortic valve Aortic Stenosis TAVR 40

Dr. S. Venkatesan MD

JANUARY 17, 2025

We know TAVI is in the striking distance , to literally take over most aortic valve interventions. That is putting together death, stroke, and unplanned hospital admission as a combined endpoint in the same basket. Thanks to the hardware, expertise, and motivation from multiple forces. You can presume what could be the reason.

TAVR 52

TAVR Aortic valve Hospital Academic 52

European Journal of Heart Failure

JANUARY 31, 2024

ABSTRACT Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes. The use of transcatheter aortic valve replacement (TAVR) has become the preferred therapy for most patients with AS and concomitant HF.

Aortic valve 40

Aortic valve Heart Failure Aortic TAVR 40

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundCerebral embolic protection devices (CEPD) capture embolic material in an attempt to reduce ischemic brain injury during transcatheter aortic valve replacement. Primary clinical outcome was all‐cause stroke. Secondary clinical outcomes were disabling stroke and all‐cause mortality.

Aortic valve 40

Aortic valve Embolism Aortic Strokes 40

Journal of the American Heart Association

MARCH 21, 2025

BackgroundCurrent guidelines and expert consensus recommend lifelong single antiplatelet therapy for patients undergoing transcatheter aortic valve replacement who have no indication for anticoagulation or dual antiplatelet therapy. Journal of the American Heart Association, Ahead of Print.

Aortic valve 40

Aortic valve Aortic Myocardial Infarction TAVR 40

American College of Cardiology

FEBRUARY 18, 2025

The EARLY TAVR trial results demonstrate that early transcatheter aortic valve implantation in patients with asymptomatic severe aortic stenosis is superior to clinical surveillance in significantly reducing the composite primary outcome of death, stroke, or unplanned hospitalization for cardiovascular causes.

Stenosis 61

Stenosis Aortic Aortic valve TAVR 61

The British Journal of Cardiology

FEBRUARY 20, 2024

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with BAV. to 4.58, p=0.04).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic TAVR 40

Journal of the American Heart Association

AUGUST 26, 2024

Journal of the American Heart Association, Ahead of Print.

Aortic valve 45

Aortic valve Aortic Strokes Stroke 45

Open Heart

MARCH 27, 2024

Objective A paucity of data exists on how transcatheter aortic valve implantation (TAVI) practice has evolved in Ireland. At 1-year follow-up, the rate of death and/or stroke was similar in Group A and Group C (20.3% The median length of hospital stay reduced from 9 days (IQR 7, 18) in Group A to 2 days (IQR 2, 3) in Group C.

Aortic valve 52

Aortic valve Aortic Outcomes Hospital 52

Circulation: Cardiovascular Quality & Outcomes

MARCH 28, 2025

In this study, we evaluate the accuracy of claims algorithms previously validated in FFS to assess comorbidities and outcomes in MA patients after aortic valve replacement.METHODS:We compared the concordance of 11 claims-based covariates (diabetes, hypertension, atrial flutter/fibrillation, myocardial infarction) and outcomes (stroke, disabling stroke, (..)

Medicare 40

Medicare Aortic valve Atrial Flutter Aortic 40

Circulation

NOVEMBER 11, 2024

Introduction:Subclinical leaflet thrombosis is an increasingly recognized complication in patients undergoing transcatheter aortic valve replacement (TAVR). Patients with hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) have a higher incidence of strokes and transient ischemic attacks.

Aortic valve 40

Aortic valve Thrombosis Aortic TAVR 40

Journal of the American Heart Association

FEBRUARY 14, 2025

BackgroundValveinvalve transcatheter aortic valve replacement (TAVR) is a recognized alternative for treating the structural valve deterioration of bioprosthetic valves. Recent guidelines and trials have expanded the indications for TAVR to include younger patients with structural valve deterioration.

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

DAIC

JUNE 25, 2024

HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more. It’s an honor to have the U.S.’s

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105